Jardiance 10 mg tablets

Jardiance is a widely recognized brand of empagliflozin, a medication primarily used to treat type 2 diabetes and chronic heart failure. It was developed through a strategic alliance between two pharmaceutical giants: Boehringer Ingelheim and Eli Lilly and Company.

The medication is fundamentally a German innovation by Boehringer Ingelheim, which remains its primary developer and owner. Production is carried out globally, with significant manufacturing facilities located in Germany (such as Biberach or Ingelheim) and through partnerships with Eli Lilly in the United States. Global distribution is handled via both companies' networks depending on the specific territory and regulatory agreements.